Industry News
Two Gene Mutations Responsible For Infantile Myofibromatosis Identified
May 27, 2013
Researchers at Mount Sinai have identified two mutations responsible for the development of infantile myofibromatosis (IM) - a tumor disorder of the skin, bone, and tissue. The finding, published in The American Journal of Human Genetics, is crucial for the development of treatment options for the disease, providing new therapeutic drug targets... Read More
Identifying Abnormally Activated Genes To Predict Cancer Virulence
May 27, 2013
Scientists have found a new way of tackling cancer and predicting the virulence of tumors, an article published in Science Translational Medicine (May 22nd 2013 issue) reported. The researchers, from the Institut Albert Bonniot de Grenoble, CNRS, Inserm and Université Joseph Fourier, all in France, worked together with doctors and anatomopathologists from the CHU de Grenoble... Read More
When Patients Develop Bloodstream Infections, Hospitals Profit
May 27, 2013
Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units... Read More
Potential New Inhaled Treatment For Lung Cancer
May 26, 2013
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors... Read More
Targeting Cell 'Powerhouses' To Overcome Resistance To Anti-Cancer Drugs
May 26, 2013
Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting. That's the conclusion of a new study published in the journal ACS Chemical Biology... Read More
Algorithm Developed Offering New Guidelines On Blood-Ordering For Surgical Patients
May 26, 2013
Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients. The recommendations, based on a lengthy study of blood use at The Johns Hopkins Hospital (JHH), can potentially save the medical center more than $200,000 a year and improve patient safety, researchers say... Read More
Anti-Cancer Drug Reverses Alzheimer's Disease In Mice
May 25, 2013
An anti-cancer drug may reverse memory problems in an Alzheimer's Disease mouse model, according to new research carried out at the University of Pittsburgh Graduate School of Public Health. The study, published in the journal Science, examined previously published outcomes on the drug bexarotene - which is approved by the U.S... Read More
Astellas Receives Marketing Authorisation For Vesomnitm From The Netherlands Medicines Evaluation Board
May 25, 2013
Netherlands first to approve new fixed-dose combination treatment for men with lower urinary tract symptoms associated with BPH ASTELLAS PHARMA EUROPE B.V., the European subsidiary of Tokyo-based Astellas Pharma Inc.(Tokyo:4503), have announced the Dutch Medicines Evaluation Board (MEB) has granted marketing authorisation for VESOMNI in the Netherlands... Read More
Anti-Cancer Drug Reverses Alzheimer's Disease In Mice
May 25, 2013
An anti-cancer drug may reverse memory problems in an Alzheimer's Disease mouse model, according to new research carried out at the University of Pittsburgh Graduate School of Public Health. The study, published in the journal Science, examined previously published outcomes on the drug bexarotene - which is approved by the U.S... Read More
Intensified, Liposomal Anthracycline-Based Chemo Regimen For Children With Leukemia May Offer High Survival Rates Without Added Heart Toxicity
May 25, 2013
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH)... Read More
Previous Page Next Page